《Human Psychopharmacology-clinical And Experimental》雜志的最新年發(fā)文量為22篇。
這表明該刊在每年都會(huì)精選并發(fā)表一定數(shù)量的高質(zhì)量文章，以保持其在臨床神經(jīng)病學(xué)領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于醫(yī)學(xué)-臨床神經(jīng)病學(xué)領(lǐng)域的前沿研究，致力于推動(dòng)該領(lǐng)域新技術(shù)和新知識(shí)的傳播與應(yīng)用。同時(shí)它積極鼓勵(lì)研究人員詳細(xì)發(fā)表其高質(zhì)量的實(shí)驗(yàn)研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Human Psychopharmacology-clinical And Experimental 雜志發(fā)文統(tǒng)計(jì)
文章名稱引用次數(shù)
- Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-20177
- Alcohol mixed with energy drink (AMED): A critical review and meta-analysis7
- Treatments used for obsessive-compulsive disorder-An international perspective7
- Memory and attention during an alcohol hangover6
- Thyroid structure and function in long-term lithium-treated and lithium-naive bipolar patients5
- Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options5
- The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants4
- Medical aromatherapy revisited-Basic mechanisms, critique, and a new development3
- The relationship between the serotonin 2A receptor gene-1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients3
- Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate3
國家/地區(qū)發(fā)文量
- USA36
- Australia19
- CHINA MAINLAND15
- Italy15
- England14
- Netherlands12
- Japan9
- GERMANY (FED REP GER)8
- Canada7
- Spain6
